The above results demonstrated the ability of IFNγ to reduce CXCL8 secretion in BCPAP cells and deserved to be confirmed in terms of ability to interfere with any of the CXCL8 mediated tumor-promoting activities. The gene discussed is IFNG; the disease is neoplasm.